InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+27.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Davis Todd C, Director. Officer active across 5 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 30 disclosures have been logged. Split: 5 buys · 0 sell. Total volume traded: €602k. History available since 4 June 2021. The latest transaction was filed on 30 June 2026 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Davis Todd C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
132 shares@ US$160.70950.0003% mcap1.7% of flowCommon StockSEC:0002001011-26-000106:0
35,445 sharesCommon StockSEC:0001919246-26-000088:0
Canonical exit: 9 Sept 2026 (T+90)
503 sharesCommon StockSEC:0001919246-26-000088:1
Canonical exit: 9 Sept 2026 (T+90)
19,108 shares0Common StockSEC:0001919246-26-000046:2
12,900 shares0Common StockSEC:0001919246-26-000046:0
4,961 shares0Common StockSEC:0001919246-26-000046:1
10,495 shares0Common StockSEC:0002001011-26-000033:0
20,782 shares0Common StockSEC:0002001011-26-000011:0
130 shares0Common StockSEC:0002001011-25-000121:0
1,500,000 shares@ US$10.00100.0% of flowCommon StockSEC:0001753926-25-001075:0
233 shares@ US$91.07751.6% of flowCommon StockSEC:0002001011-25-000050:0
1,680 shares@ US$104.5714.7% of flowCommon StockSEC:0002001011-25-000029:0
Canonical exit: 7 Aug 2025 (T+90)
21,382 shares0Common StockSEC:0002001011-25-000014:0
20,784 shares0Common StockSEC:0002001011-25-000013:0
2,500 shares@ US$97.392220.9% of flowCommon StockSEC:0002001011-24-000067:0
Canonical exit: 6 Nov 2024 (T+90)
350 shares@ US$60.7071.9% of flowCommon StockSEC:0002001011-24-000062:0
7,448 shares@ US$46.2029.9% of flowCommon StockSEC:0002001011-24-000035:0
32,436 shares0Common StockSEC:0002001011-24-000027:0
29,167 shares@ US$4.80100.0% of flowCommon StockSEC:0001753926-24-000374:0
1,381 shares@ US$74.659.0% of flowCommon StockSEC:0002001011-24-000016:0
4,000 shares@ US$59.382288.6% of flowCommon StockSEC:0000886163-23-000057:0
Canonical exit: 21 Dec 2023 (T+90)
420 shares@ US$73.762.7% of flowCommon StockSEC:0000886163-23-000038:0
17,005 shares0Common StockSEC:0000899243-23-006294:0
7,375 shares0Common StockSEC:0001437749-22-019437:0
1,004 shares0Common StockSEC:0000886163-22-000082:0
25 of 30 declarations
About Davis Todd C
Davis Todd C is Administrateur and has 30 filings in total. Across the 30 filings tracked, the recent sampled filings run from 2021-06-07 to 2026-07-06, with EUR 602361 of buys and EUR 0 of sells. They are associated with Ligand Pharmaceuticals INC, Pelthos Therapeutics Inc., Biodelivery Sciences International INC, Vaxart, Inc. and Chromocell Therapeutics Corp.
